Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

ACC news: preliminary clinical results presented for Chiron's rFGF-2 angiogenesis therapy

March 15, 2000

Baxter exercises option in cardiovascular collaboration with Sangamo

March 15, 2000

New treatment options for restenosis a hot topic at ACC

March 14, 2000

Exochelin has potential in restenosis, according to data presented to the ACC

March 14, 2000

Integrin receptor blockade assessed at DuPont for angiogenesis-mediated disorders

March 14, 2000

Back in the limelight: vasopeptidase inhibitor omapatrilat featured at ACC

March 14, 2000

Santen presents new chymase inhibitors especially for cardiovascular disorders

March 14, 2000

BMS-193884 safely improves hemodynamics in heart failure patients; data presented to ACC

March 13, 2000

Shionogi prepares chymase/cytokine inhibitors with beta-lactam structure

March 13, 2000

Connetics files IND for a phase II trial to evaluate ConXn in peripheral vascular disease

March 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...